These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7582066)

  • 41. Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease.
    Usami T; Kimura G
    Clin Exp Nephrol; 2006 Mar; 10(1):8-12. PubMed ID: 16544172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The rationale for early management of chronic renal insufficiency.
    Muirhead N
    Nephrol Dial Transplant; 2001; 16 Suppl 7():51-6. PubMed ID: 11590258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can the rate of progression of chronic renal failure be altered?
    Kirkpatrick WG
    Am J Med Sci; 1990 Dec; 300(6):396-401. PubMed ID: 2264580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The calcium antagonists in the 1990s. An overview.
    Oparil S; Calhoun DA
    Am J Hypertens; 1991 Jul; 4(7 Pt 2):396S-405S. PubMed ID: 1910636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The renin-angiotensin system biomolecular cascade: a 2022 update of newer insights and concepts.
    Ferrario CM; Groban L; Wang H; Sun X; VonCannon JL; Wright KN; Ahmad S
    Kidney Int Suppl (2011); 2022 Apr; 12(1):36-47. PubMed ID: 35529089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of ACE inhibitors and calcium antagonists on progression of chronic renal disease.
    Epstein M
    Blood Press Suppl; 1995; 2():108-12. PubMed ID: 7582066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertension as a risk factor for progression of chronic renal disease.
    Epstein M
    Blood Press Suppl; 1994; 1():23-8. PubMed ID: 8205294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
    Lenz T; August P
    Wien Klin Wochenschr; 1990 May; 102(11):315-9. PubMed ID: 2195780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium antagonists and renal protection: emerging perspectives.
    Epstein M
    J Hypertens Suppl; 1998 Sep; 16(4):S17-25. PubMed ID: 9817188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.